Bulletin of RSMU

OPINION

Development of liposomal drug formulations: quality attributes and methods for quality control

Melnikova EV, Goryachev DV, Chaplenko AA, Vodyakova MA, Sayfutdinova AR, Merkulov VA

Scientific center for expert evaluation of medicinal products of the Ministry of health of the Russian Federation, Moscow

Correspondence should be addressed: Alexander A. Chaplenko
Shchukinskaya, 6 bl. 1, Moscow, 127051; ur.dempxe@oknelpahc

About paper

Received: 2018-06-29 Accepted: 2018-09-02 Published online: 2018-12-31

Fig. 1. Information about the quality characteristics of liposomal drug formulations

Table 1. Use of different types of liposomes for drug delivery

Table 2. Liposome-based drugs characteristics

Table 3. Regulatory documents containing requirements to liposomal drug

Link to the next paper will be sent to the indicated e-mail's:

OPINION Development of liposomal drug formulations: quality attributes and methods for quality control

Melnikova EV, Goryachev DV, Chaplenko AA, Vodyakova MA, Sayfutdinova AR, Merkulov VA

Published in "Bulletin of RSMU" 6, 2018

I want to receive a copy of this message

Vancouver style

Melnikova EV, Goryachev DV, Chaplenko AA, Vodyakova MA, Sayfutdinova AR, Merkulov VA. Development of liposomal drug formulations: quality attributes and methods for quality control. Bulletin of RSMU. 2018; (6): 33–9. DOI: 10.24075/brsmu.2018.092

Harvard style

Melnikova, E. V., Goryachev, D. V., Chaplenko, A. A., Vodyakova, M. A., Sayfutdinova, A. R. and Merkulov, V. A. (2018), "Development of liposomal drug formulations: quality attributes and methods for quality control", Bulletin of RSMU, no. 6, p. 33–39. DOI: 10.24075/brsmu.2018.092

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2018 / 06

OPINION

Development of liposomal drug formulations: quality attributes and methods for quality control